| Primary |
| Product Used For Unknown Indication |
49.6% |
| Pneumonia |
9.6% |
| Atrial Fibrillation |
5.6% |
| Cardiac Flutter |
4.0% |
| Lung Infection |
3.2% |
| Osteomyelitis |
3.2% |
| Systemic Candida |
3.2% |
| Urinary Tract Infection |
3.2% |
| Haemoptysis |
2.4% |
| Hepatic Function Abnormal |
2.4% |
| Leukaemia |
2.4% |
| Cerebral Infarction |
1.6% |
| Diabetic Foot |
1.6% |
| Rash |
1.6% |
| Sepsis |
1.6% |
| Urosepsis |
1.6% |
| Abdominal Infection |
0.8% |
| Bacterial Infection |
0.8% |
| Candidiasis |
0.8% |
| Febrile Neutropenia |
0.8% |
|
| Petechiae |
14.7% |
| Grand Mal Convulsion |
11.8% |
| Epilepsy |
8.8% |
| Rash |
8.8% |
| Convulsion |
5.9% |
| Pruritus |
5.9% |
| Thrombocytopenia |
5.9% |
| Angioedema |
2.9% |
| Candida Test Positive |
2.9% |
| Cholangitis Sclerosing |
2.9% |
| Drug Eruption |
2.9% |
| Liver Abscess |
2.9% |
| Mental Status Changes |
2.9% |
| Partial Seizures |
2.9% |
| Postoperative Wound Infection |
2.9% |
| Proteus Test Positive |
2.9% |
| Respiratory Depression |
2.9% |
| Respiratory Failure |
2.9% |
| Tachypnoea |
2.9% |
| Toxic Epidermal Necrolysis |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
18.5% |
| Drug Use For Unknown Indication |
16.8% |
| Sepsis |
13.1% |
| Infection |
7.1% |
| Mediastinal Abscess |
4.6% |
| Retroperitoneal Abscess |
4.6% |
| Upper Respiratory Tract Inflammation |
4.6% |
| Bacterial Infection |
4.3% |
| Lung Abscess |
3.4% |
| Mediastinitis |
3.4% |
| Acute Myeloid Leukaemia |
2.8% |
| Pain |
2.3% |
| Renal Transplant |
2.3% |
| Depression |
2.0% |
| Escherichia Sepsis |
2.0% |
| Atrial Fibrillation |
1.7% |
| Blood Beta-d-glucan Abnormal |
1.7% |
| Endocarditis |
1.7% |
| Rhabdomyosarcoma |
1.7% |
| Lung Infection |
1.4% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
14.0% |
| Lactase Deficiency |
10.5% |
| Cholestatic Liver Injury |
7.0% |
| Deafness |
7.0% |
| Pneumonia |
7.0% |
| Coagulation Factor V Level Decreased |
5.3% |
| Agranulocytosis |
3.5% |
| Cholecystitis |
3.5% |
| Clostridium Difficile Colitis |
3.5% |
| Convulsion |
3.5% |
| Drug Eruption |
3.5% |
| Grand Mal Convulsion |
3.5% |
| Leukocytoclastic Vasculitis |
3.5% |
| Liver Injury |
3.5% |
| Necrotising Ulcerative Gingivostomatitis |
3.5% |
| Nephritis Allergic |
3.5% |
| Nephrogenic Diabetes Insipidus |
3.5% |
| Peritonitis Sclerosing |
3.5% |
| Proteus Test Positive |
3.5% |
| Sepsis |
3.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.3% |
| Product Used For Unknown Indication |
29.3% |
| Prophylaxis |
4.1% |
| Hypertension |
3.8% |
| Pain |
3.3% |
| Febrile Neutropenia |
3.1% |
| Infection Prophylaxis |
2.6% |
| Pseudomonas Infection |
2.5% |
| Prostate Cancer |
2.3% |
| Proteus Infection |
2.3% |
| Rash |
2.3% |
| Postoperative Fever |
1.8% |
| Thrombosis Prophylaxis |
1.5% |
| Infection |
1.5% |
| Candidiasis |
1.4% |
| Pyrexia |
1.4% |
| Renal Transplant |
1.3% |
| Bone Marrow Conditioning Regimen |
1.2% |
| Rheumatoid Arthritis |
1.1% |
| Acute Lymphocytic Leukaemia |
1.0% |
|
| Vomiting |
10.0% |
| Gastrointestinal Perforation |
8.9% |
| Thrombocytopenia |
7.8% |
| Death |
6.7% |
| International Normalised Ratio Increased |
6.7% |
| Febrile Neutropenia |
5.6% |
| Hypotension |
5.6% |
| Pneumonia |
5.6% |
| Pneumonia Bacterial |
5.6% |
| Renal Failure Acute |
5.6% |
| Pancytopenia |
4.4% |
| Septic Shock |
4.4% |
| Intestinal Perforation |
3.3% |
| Leukopenia |
3.3% |
| Nephropathy Toxic |
3.3% |
| Respiratory Failure |
3.3% |
| Weight Decreased |
3.3% |
| Agitation |
2.2% |
| Bone Marrow Failure |
2.2% |
| Bradycardia |
2.2% |
|
| Interacting |
|
| Anaemia |
25.0% |
| Haematemesis |
25.0% |
| International Normalised Ratio Increased |
25.0% |
| Overdose |
25.0% |
|
